New Deployable Expandable Electrodes in the Electroporation Treatment in a Pig Model: A Feasibility and Usability Preliminary Study.

colon-rectal district electroporation liver new electrodes oral cavity

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 Feb 2020
Historique:
received: 18 01 2020
revised: 20 02 2020
accepted: 20 02 2020
entrez: 28 2 2020
pubmed: 28 2 2020
medline: 28 2 2020
Statut: epublish

Résumé

The aim of the study is to evaluate the usability aspects of new deployable, expandable, electrode prototypes, in terms of suitability solutions for laparoscopic applications on the liver, endoscopic trans-oral and trans-anal procedures, electroporation segmentation in several steps, mechanical functionality (flexibility, penetrability), visibility of the electrode under instrumental guidance, compatibility of the electrode with laparoscopic/endoscopic accesses, surgical instruments, and procedural room and safety compatibility. The electroporation was performed on an animal model (Sus Scrofa Large White 60 kg) both in laparoscopy and endoscopy, under ultrasound guidance, and in open surgery. Electrodes without divergence, with needles coming out straight, parallel to each other, and electrodes with peripheral needles (four needles), diverging from the electrode shaft axis (electrode with non-zero divergence) have been tested. To cause an evaluable necrosis effect, the number of electrical pulses was increased to induce immediate liver cell death. Histological samples were analyzed by staining with Haematoxylin/Eosin or by immunohistochemical staining to confirm complete necrosis. The prototypes of expandable electrodes, tested in laparoscopy and endoscopy and in open surgery, respectively, are suitable in terms of usability, electroporation segmentation in several steps, mechanical functionality (flexibility, penetrability), visibility under instrumental guidance, compatibility with laparoscopic/endoscopic accesses, surgical instruments and procedural room safety, patient safety (no bleeding and/or perforation), and treatment efficacy (adequate ablated volume). Electroporation treatment using new deployable expandable electrode prototypes is safe and feasible. Moreover, electrode configurations allow for a gradual increase in the ablated area in consecutive steps, as confirmed by histology and immunohistochemistry.

Identifiants

pubmed: 32102182
pii: cancers12020515
doi: 10.3390/cancers12020515
pmc: PMC7072261
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur J Surg Oncol. 2018 May;44(5):651-657
pubmed: 29402556
BMJ Open. 2016 Nov 3;6(11):e012977
pubmed: 27810978
Bioelectrochemistry. 2011 Apr;81(1):10-6
pubmed: 21256816
Acta Oncol. 2018 Jul;57(7):874-882
pubmed: 29577784
Eur J Surg Oncol. 2013 Jan;39(1):4-16
pubmed: 22980492
Diagn Interv Imaging. 2019 May;100(5):309-311
pubmed: 30691970
World J Gastroenterol. 2017 Jul 14;23(26):4767-4778
pubmed: 28765698
Expert Rev Anticancer Ther. 2010 May;10(5):729-46
pubmed: 20470005
Ann Surg. 2015 Sep;262(3):486-94; discussion 492-4
pubmed: 26258317
Gastrointest Endosc. 2018 Jan;87(1):300.e1-300.e6
pubmed: 28501593
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818785329
pubmed: 29986632
Physiol Meas. 2009 May;30(5):459-66
pubmed: 19349647
Int J Surg. 2015 Sep;21 Suppl 1:S78-82
pubmed: 26123385
Int J Surg. 2015 Jun;18:230-6
pubmed: 25917204
PLoS One. 2014 Aug 12;9(8):e103083
pubmed: 25115970
Aliment Pharmacol Ther. 2018 Sep;48(6):671-681
pubmed: 30063081
Surg Technol Int. 2019 Oct 4;35:71-83
pubmed: 31710087
IEEE Trans Biomed Eng. 2006 Jul;53(7):1409-15
pubmed: 16830945
Clin Epidemiol. 2012;4:283-301
pubmed: 23152705
Future Oncol. 2014 Apr;10(5):877-90
pubmed: 24799067
Future Oncol. 2010 Jul;6(7):1061-4
pubmed: 20624116
Biomed Eng Online. 2010 Feb 23;9:10
pubmed: 20178589
Eur J Surg Oncol. 2008 Feb;34(2):232-40
pubmed: 17614247
Bioelectromagnetics. 2015 Dec;36(8):603-12
pubmed: 26508012
BMJ Open. 2020 Feb 10;10(2):e033490
pubmed: 32047015
Radiol Oncol. 2012 Dec;46(4):271-8
pubmed: 23412694
Radiol Oncol. 2015 Mar 25;49(2):147-54
pubmed: 26029026
Cardiovasc Intervent Radiol. 2020 Jan;43(1):84-93
pubmed: 31385006
J Vasc Interv Radiol. 2016 Sep;27(9):1441-1450.e2
pubmed: 27475242
Med Biol Eng Comput. 2012 Dec;50(12):1213-25
pubmed: 23179413
World J Surg. 2016 Dec;40(12):3088-3094
pubmed: 27443372
Biomed Eng Online. 2014 Mar 12;13(1):29
pubmed: 24621079
Technol Cancer Res Treat. 2004 Dec;3(6):599-609
pubmed: 15560718
Oncologist. 2019 Oct;24(10):e990-e1005
pubmed: 31217342
World J Methodol. 2015 Dec 26;5(4):238-54
pubmed: 26713285
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809994
pubmed: 30411673
Radiol Oncol. 2016 Feb 16;50(1):14-20
pubmed: 27069445
Acta Otorhinolaryngol Ital. 2018 Jun;38(3):181-187
pubmed: 29984793
World J Gastroenterol. 2017 Feb 7;23(5):906-918
pubmed: 28223736
J Thorac Cardiovasc Surg. 2018 May;155(5):2150-2159.e3
pubmed: 29358001
J Clin Oncol. 2014 Oct 1;32(28):3144-55
pubmed: 25154827
Technol Cancer Res Treat. 2011 Oct;10(5):475-85
pubmed: 21895032
Cancer Res. 2011 Jun 1;71(11):3753-62
pubmed: 21507935

Auteurs

Francesco Izzo (F)

Division of Surgical Oncology, Hepatobiliary Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Franco Ionna (F)

Division of Surgical Oncology, Maxillo-Facial Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Vincenza Granata (V)

Division of Radiodiagnostic, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Vittorio Albino (V)

Division of Surgical Oncology, Hepatobiliary Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Renato Patrone (R)

Division of General and Oncologic Surgery, Department of Cardiothoracic Sciences, UNIVERSITA' DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI, NAPOLI, ITALIA, 80131 Naples, Italy.

Francesco Longo (F)

Division of Surgical Oncology, Maxillo-Facial Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Agostino Guida (A)

Division of Surgical Oncology, Maxillo-Facial Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Paolo Delrio (P)

Division of Surgical Oncology, Colo-Rectal Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Daniela Rega (D)

Division of Surgical Oncology, Colo-Rectal Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Dario Scala (D)

Division of Surgical Oncology, Colo-Rectal Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Roberto Pezzuto (R)

Division of Surgical Oncology, Colo-Rectal Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Roberta Fusco (R)

Research & Development Division, Igea SpA, Via Casarea 65, Casalnuovo di Napoli, 80013 Naples, Italy.

Elio Di Bernardo (E)

Research & Development Division, Igea SpA, Via Casarea 65, Casalnuovo di Napoli, 80013 Naples, Italy.

Valeria D'Alessio (V)

Research & Development Division, Igea SpA, Via Casarea 65, Casalnuovo di Napoli, 80013 Naples, Italy.

Roberto Grassi (R)

Division of Radiodiagnostic, UNIVERSITA' DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI, NAPOLI, ITALIA, Via Miraglia, 80143 Naples, Italy.

Deyanira Contartese (D)

Laboratory Preclinical and Surgical Studies, IRCCS-ISTITUTO ORTOPEDICO RIZZOLI, Via di Barbiano 1/10, 40136 Bologna, Italy.

Raffaele Palaia (R)

Division of Surgical Oncology, Hepatobiliary Unit, ISTITUTO NAZIONALE TUMORI-IRCCS-FONDAZIONE G. PASCALE, NAPOLI, ITALIA, Via Mariano Semmola, 80131 Naples, Italy.

Classifications MeSH